ABSTRACT OBJECTIVES This study sought to evaluate the effectiveness of intravenous (IV) diuretic treatment for volume management in heart failure (HF).
Limited data are available regarding the use of IV diuretics for the ambulatory treatment of decompensated HF (3) (4) (5) (6) (7) (8) . Although several studies provide clinicians with guidance on diuretic dosing strategies for hospitalized patients, no such guidance exists for use in ambulatory patients (9) (10) (11) (12) . It also remains unclear whether a strategy of ambulatory IV diuretic administration is a reasonable alternative to hospital admission for selected patients with worsening HF. In this paper, we report on the safety and efficacy of IV diuretic administration according to a standardized dosing guideline used in our ambulatory HF treatment unit. OUTCOMES. The outcomes of IV diuretic treatment by clinic visit are described in Table 3 , and by protocol group in Table 4 . The median urine output was 1,045 ml (IQR: 619 to 1,400 ml). The median clinic weight loss was 1 kg (IQR: 0.6 to 1.3 kg). The median home weight loss was 1.1 kg (IQR: 0.2 to 1.9 kg). There were no differences between patients with HFrEF and HFpEF ( Figure 3 Two patients were directly admitted to the hospital after their first ambulatory treatment attempt due to Time to laboratory follow-up, days
Values are n (%) or median (interquartile range). *Milligrams of intravenous furosemide per visit.
Abbreviations as in Table 1 . were predominantly related to previous intolerance, which is known to be an additional marker of more severe disease (20) . Notably, these rates are compara- Accordingly, these data suggest that a protocolized approach to ambulatory IV diuresis may be a safe and effective route to relief of congestion without hospitalization for both patients with HFpEF and HFrEF.
In the absence of clear guidance from previous studies, our diuretic dosing strategy was adapted from the Diuretic Optimization Strategies Evaluation trial of
FIGURE 3 Efficacy Outcomes in Notable Subgroups
Weight loss was expressed in kilograms and urine output in liters. Outcomes were similar between patients with heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF). Successful decongestion was achieved in the majority of patients. 
